Copper peptides utilize the skin's biochemical systems that remove the old, hard cells and damaged proteins and replace them with new skin and new proteins
Why Compounding Access Is Not an Established Path Positioning in the Metabolic Medicine Conversation For physicians fielding patient questions about 5-amino-1MQ, the appropriate framing: Promising mechanism with solid preclinical rationale Early clinical development human efficacy and safety not yet well characterized No legitimate clinical access pathway in the United States as of 2026 Alternative evidence-based options exist for the underlying metabolic optimization goals patients typically pursue Key Takeaways 5-amino-1MQ is a small-molecule NNMT inhibitor, not a peptide
I can't tell you how many cans of cat food I've binned
If your levels remain low despite supplementation, it may be a sign that there is an underlying source of inflammation or toxin exposure that needs to be addressed at the foundational level
Human Uterine Leiomyomata Express Higher Levels of Peroxisome Proliferator-Activated Receptor Gamma, Retinoid X Receptor Alpha, and All-Trans Retinoic Acid Than Myometrium
doi:10.1016/j.biochi.2016.02.012 [PubMed] [Elsevier] Hanna M, Jaqua E, Nguyen V, Clay J